Northeast Pharmaceutical Group Co Ltd (000597) — Capital Reinvestment Ratio
Northeast Pharmaceutical Group Co Ltd (000597) has a Capital Reinvestment Ratio of 0.04x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥274.09 Million) in capital expenditures (CN¥11.48 Million). See free cash flow generation of Northeast Pharmaceutical Group Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Northeast Pharmaceutical Group Co Ltd Capital Reinvestment Ratio (1999–2025)
This chart tracks Northeast Pharmaceutical Group Co Ltd's Capital Reinvestment Ratio across 23 annual periods.
Annual Capital Reinvestment Ratio for Northeast Pharmaceutical Group Co Ltd (1999–2025)
Year-by-year Capital Reinvestment Ratio for Northeast Pharmaceutical Group Co Ltd from 1999 to 2025. For live market cap and broader valuation context, see 000597 stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.09x | CN¥1.11 Billion | CN¥97.78 Million | ▼ -57.9% |
| 2024 | 0.21x | CN¥758.76 Million | CN¥159.43 Million | ▼ -47.6% |
| 2023 | 0.40x | CN¥586.75 Million | CN¥235.43 Million | ▲ +82.2% |
| 2022 | 0.22x | CN¥1.11 Billion | CN¥244.13 Million | ▲ +37.2% |
| 2021 | 0.16x | CN¥746.51 Million | CN¥119.81 Million | ▼ -77.1% |
| 2020 | 0.70x | CN¥570.92 Million | CN¥400.38 Million | ▲ +7.9% |
| 2019 | 0.65x | CN¥352.60 Million | CN¥229.17 Million | ▼ -67.2% |
| 2018 | 1.98x | CN¥285.09 Million | CN¥565.74 Million | ▲ +331.1% |
| 2016 | 0.46x | CN¥384.51 Million | CN¥177.01 Million | ▼ -86.7% |
| 2015 | 3.47x | CN¥99.70 Million | CN¥346.04 Million | ▼ -69.4% |
| 2014 | 11.33x | CN¥46.99 Million | CN¥532.27 Million | ▲ +445.1% |
| 2012 | 2.08x | CN¥86.09 Million | CN¥178.90 Million | ▲ +12.2% |
| 2010 | 1.85x | CN¥255.96 Million | CN¥473.93 Million | ▲ +32.2% |
| 2009 | 1.40x | CN¥615.91 Million | CN¥862.78 Million | ▲ +176.5% |
| 2008 | 0.51x | CN¥709.03 Million | CN¥359.27 Million | ▲ +14.6% |
| 2007 | 0.44x | CN¥198.56 Million | CN¥87.78 Million | ▼ -52.5% |
| 2005 | 0.93x | CN¥111.40 Million | CN¥103.66 Million | ▲ +221.2% |
| 2004 | 0.29x | CN¥211.06 Million | CN¥61.14 Million | ▼ -23.8% |
| 2003 | 0.38x | CN¥230.08 Million | CN¥87.46 Million | ▲ +57.1% |
| 2002 | 0.24x | CN¥157.41 Million | CN¥38.07 Million | ▼ -59.1% |
| 2001 | 0.59x | CN¥78.84 Million | CN¥46.57 Million | ▲ +75.2% |
| 2000 | 0.34x | CN¥36.13 Million | CN¥12.18 Million | ▲ +95.9% |
| 1999 | 0.17x | CN¥54.62 Million | CN¥9.41 Million | — |